Wenfeng Yu

Title: Innovations by Wenfeng Yu in Tumor Chemotherapy

Introduction

Wenfeng Yu is an accomplished inventor based in Guiyang, China. He has made significant contributions to the field of cancer treatment through his innovative patent related to ctDNA detection. His work focuses on improving the applicability of tumor chemotherapeutic drugs.

Latest Patents

Wenfeng Yu holds a patent for a "Kit for detecting ctDNA and expression of drug-resistant genes related to applicability of tumor chemotherapeutic drugs." This kit is designed to determine ctDNA concentration using a method that involves dissolving extracted ctDNA in Tris-HCl buffer with a pH greater than 7.0. The process includes adding 2,7-bis(1-methyl-4-vinylpyridine)-9-ethylcarbazole iodised salt as a molecular probe. The concentration of ctDNA in the solution is calculated by measuring the fluorescence intensity, demonstrating extremely high sensitivity in determining ctDNA concentrations ranging from 0 µg/ml to 50 µg/ml.

Career Highlights

Wenfeng Yu has dedicated his career to advancing cancer research and treatment methodologies. His innovative approach to ctDNA detection has the potential to significantly enhance the effectiveness of chemotherapy by providing critical information about drug resistance.

Collaborations

Wenfeng Yu has collaborated with notable colleagues, including Rui Gao and Hai Zhuang, to further his research and development efforts in the field of oncology.

Conclusion

Wenfeng Yu's contributions to cancer treatment through his innovative patent highlight the importance of research in improving therapeutic strategies. His work exemplifies the potential of scientific advancements in enhancing patient care and treatment outcomes.